E. Berret
4 Papers
E. Berret is an academic researcher. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis
Johannes A. Kroes,Rafael Alfonso-Cristancho,Aruna T. Bansal,E. Berret,Kristina Bieksiene,Arnaud Bourdin,Luisa Brussino,Diogo Canhoto,Cristina Cardini,Gülfem Çelik,Zsuzsanna Csoma,Barbro Dahlén,Ebru Damadoğlu,Katrien Eger,L. Gauquelin,Bilun Gemicioglu,Ozlem Goksel,Sophie Graff,Enrico Heffler,H. Hofstee,Peter H. Howarth,R. Jakes,F. Jaun,Virginija Kalinauskaite-Zukauske,Peter Kopač,Namhee Kwon,Cláudia Chaves Loureiro,V. Lozoya García,Matthew Masoli,M. Rezelj,Luis Pérez de Llano,Sanja Popović-Grle,David Ramos-Barbón,Ana Sá Sousa,Konstantinos Samitas,Florence Schleich,Concetta Sirena,Sabina Skrgat,Eleftherios Zervas,G. Zichnalis,Elisabeth H. Bel,Jacob K. Sont,Simone Hashimoto,Anneke ten Brinke +43 more
TL;DR: In this paper , the authors used federated analysis to compare the real-world effectiveness of mepolizumab on asthma exacerbations and maintenance oral glucocorticoid (OCS) use in severe asthma patients across Europe.
Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data
Johannes A. Kroes,Rafael Alfonso-Cristancho,Aruna T. Bansal,E. Berret,Kristina Bieksiene,Aline Bourdin,Luisa Brussino,D. Canhoto,Cristina Cardini,G Celik,Zsuzsanna Csoma,Babro Dahlen,Ebru Damadoğlu,Katrien Eger,L Gauquelin,Bilun Gemicioglu,Ozlem Goksel,Sophie Graff,Enrico Heffler,H. Hofstee,Peter H. Howarth,R. Jakes,F. Jaun,Virginija Kalinauskaite-Zukauske,Peter Kopač,Namhee Kwon,Cláudia Chaves Loureiro,V. Lozoya García,Matthew Masoli,M. Paula Rezelj,Luis Pérez de Llano,Sanja Popović-Grle,David Ramos-Barbón,Ana Sá Sousa,Konstantinos Samitas,Florence Schleich,Concetta Sirena,Sabina Skrgat,Eleftherios Zervas,G. Zichnalis,Elisabeth H. Bel,Jacob K. Sont,Simone Hashimoto,Anneke ten Brinke +43 more
- 04 Sep 2022
TL;DR: In this paper , the authors used federated analysis to evaluate the effectiveness of mepolizumab on frequent (≥2/yr) exacerbations in patients with severe asthma.
Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
Johannes A. Kroes,Aruna T. Bansal,E. Berret,Nils Christian,Andreas Kremer,Anna Alloni,Matteo Gabetta,Chris Marshall,Scott Wagers,Ratko Djukanovic,Celeste Porsbjerg,Dominique Hamerlijnck,Olivia Fulton,Anneke ten Brinke,Elisabeth H. Bel,Jacob K. Sont +15 more
TL;DR: This work describes how the European severe asthma clinical research collaboration SHARP fulfilled the harmonisation process from nonstandardised clinical registry data to the Observational Medical Outcomes Partnership Common Data Model and built a strong network of collaborators from multiple disciplines and countries.
What bothers severe asthma patients most? A paired patient–clinician study across seven European countries
Ben Ainsworth,Eleanor Chatburn,Aruna T. Bansal,Olivia Fulton,Dominique Hamerlijnck,Courtney Coleman,Katrien Eger,Michael E. Hyland,LJ Holmes,Liam G Heaney,Vratislav Sedlák,Sabina Skrgat,Natalija Edelbaher,Anneke ten Brinke,Celeste Porsbjerg,Mina Gaga,Cláudia Chaves Loureiro,Ratko Djukanovic,E. Berret,Namhee Kwon +19 more
TL;DR: In this article , the authors used a patient-centred approach to examine the most bothersome aspects of severe asthma to patients, as seen from both perspectives in asthma registries.